4//SEC Filing
Pizzuti Dana 4
Accession 0000950170-25-025665
CIK 0001658247other
Filed
Feb 23, 7:00 PM ET
Accepted
Feb 24, 4:30 PM ET
Size
7.1 KB
Accession
0000950170-25-025665
Insider Transaction Report
Form 4
Pizzuti Dana
Chief Med and Dev Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-20+65,000→ 65,000 totalExercise: $36.86Exp: 2035-02-19→ Common Stock (65,000 underlying) - Award
Common Stock
2025-02-20+43,000→ 74,748 total
Footnotes (2)
- [F1]The transaction reported on this line involves the receipt of restricted stock units, which represent the right to receive shares of the Issuer's Common Stock, with 25% vesting annually beginning on March 15, 2026.
- [F2]The stock option shall vest and become exercisable in a series of forty-eight (48) successive equal monthly installments measured from the vesting commencement date of February 20, 2025.
Documents
Issuer
Crinetics Pharmaceuticals, Inc.
CIK 0001658247
Entity typeother
Related Parties
1- filerCIK 0001948238
Filing Metadata
- Form type
- 4
- Filed
- Feb 23, 7:00 PM ET
- Accepted
- Feb 24, 4:30 PM ET
- Size
- 7.1 KB